Edwards Lifesciences Reports First Quarter Results

Edwards Lifesciences today reported financial results for the quarter ended March 31, 2024.


Highlights and Outlook



Q1 sales grew 10% on a reported and constant currency1 basis to $1.6...

Related Keywords

United States ,Canada ,Japan ,America ,Bernard Zovighian ,Edwards Lifesciences ,Drug Administration ,Facebook ,Product Group ,Youtube ,Medtronic Inc ,Linkedin ,Securities Exchange ,Exchange Commission ,Instagram ,Edwards Lifesciences Corporation ,Aortic Valve Replacement ,Tricuspid Therapies ,Structural Heart ,Latin America ,Edward Smart Recovery ,Critical Care ,Surgical Structural Heart ,Securities Act ,Securities Exchange Act ,Annual Report ,Consolidated Statements ,Generally Accepted Accounting Principles ,Litigation Expenses ,Fair Value ,Contingent Consideration Liabilities ,Intangible Assets ,Property Agreement ,Intellectual Property Agreement ,Income Taxes ,Free Cash Flow ,Months Ended March ,Free Cash ,Markets ,